Fosun International Ltd (FNI.DU)
| Previous close | 0.5675 |
| Open | 0.5760 |
| Bid | 0.5745 x N/A |
| Ask | 0.6005 x N/A |
| Day's range | 0.5740 - 0.5760 |
| 52-week range | 0.4611 - 0.6564 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Fosun successfully completed the refinancing of approximately USD800 million loan
Fosun International Limited (HKEX stock code: 00656, "Fosun International", "Fosun" or "the Company") has successfully completed the refinancing of its USD804 million loan due on 7 May 2024. As part of the refinancing process, the Company has successfully obtained a new syndicate loan of USD597 million, while the remaining was repaid through its own funds.
- PR Newswire
FOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report
Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report"). Facing the increasingly severe challenges of global climate change, Fosun released its second Climate Information Disclosures Report with reference to the disclosure requirements of the Hong Kong Stock Exchange, the Task Force on Climate-Related Financial Disclosures ("TCFD
- PR Newswire
Fosun's Subsidiary Fidelidade Announces Listing Plan of Private Health Service Company Luz Saúde
Fidelidade, a subsidiary of Fosun International and Portugal's leading insurer, announced on Wednesday (10 April) that its subsidiary, Luz Saúde, a private healthcare service provider had communicated to the market its plan to seek admission for the trading of its shares on the Euronext Lisbon stock exchange, as part of a planned public sale offer. If realized, this operation will create better conditions for the continued expansion and growth of Luz Saúde in the health sector.
